Rodriguez-Berriguete, G., Puliyadi, R., Machado, N., Barberis, A., Prevo, R., McLaughlin, M., . . . Higgins, G. S. (2024). Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models. Cell death & disease, 15(1), 32-10. https://doi.org/10.1038/s41419-023-06405-8
Citace podle Chicago (17th ed.)Rodriguez-Berriguete, Gonzalo, Rathi Puliyadi, Nicole Machado, Alessandro Barberis, Remko Prevo, Martin McLaughlin, Francesca M. Buffa, Kevin J. Harrington, a Geoff S. Higgins. "Antitumour Effect of the Mitochondrial Complex III Inhibitor Atovaquone in Combination with Anti-PD-L1 Therapy in Mouse Cancer Models." Cell Death & Disease 15, no. 1 (2024): 32-10. https://doi.org/10.1038/s41419-023-06405-8.
Citace podle MLA (9th ed.)Rodriguez-Berriguete, Gonzalo, et al. "Antitumour Effect of the Mitochondrial Complex III Inhibitor Atovaquone in Combination with Anti-PD-L1 Therapy in Mouse Cancer Models." Cell Death & Disease, vol. 15, no. 1, 2024, pp. 32-10, https://doi.org/10.1038/s41419-023-06405-8.